Agoracom: Small Cap Investment - Resverlogix Corp. - Re: COVID-19 "competition" to keep an eye on.

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

COVID-19 "competition" to keep an eye on.

10-41

Feb 08, 2021 03:30AM

Re: COVID-19 "competition" to keep an eye on.

KOO-KOO2

Feb 08, 2021 06:23AM

Re: COVID-19 "competition" to keep an eye on.

10-41

Feb 08, 2021 06:29PM

Re: COVID-19 "competition" to keep an eye on.

tada

Feb 09, 2021 01:17PM

Re: COVID-19 "competition" to keep an eye on.

10-41

Feb 09, 2021 03:33PM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: COVID-19 "competition" to keep an eye on.

in response to

Re: COVID-19 "competition" to keep an eye on.

tada

posted on Feb 09, 2021 04:28PM

"Replacing stroke with CHF is the tweaking that has been done in the BoM2 trial along with the number of CKD patients. In theory the BoM2 numbers should be more than adequate to pass."

Don't forget that BoM2 is also planning to increase the number of patients on SGLT2i from ~12.5% in BoM to an estimated 70% in BoM2.

BDAZ

6 Recommendations

Re: COVID-19 "competition" to keep an eye on.

KOO-KOO2

Feb 09, 2021 04:47PM

Re: COVID-19 "competition" to keep an eye on.

SunClub77

Feb 11, 2021 08:55PM

Re: COVID-19 "competition" to keep an eye on.

10-41

Feb 12, 2021 03:22AM